DNMT3A c.196C>G ;(p.P66A)

Variant ID: 2-25505562-G-C

NM_022552.4(DNMT3A):c.196C>G;(p.P66A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy.

Seminars In Immunopathology
De Sanctis, Francesco F; Adamo, Annalisa A; Canè, Stefania S; Ugel, Stefano S
Publication Date: 2022-09-26

Variant appearance in text: DNMT3A: p66a
PubMed Link: 36161514
Variant Present in the following documents:
  • Main text
  • 281_2022_Article_965.pdf
View BVdb publication page



The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics.

Frontiers In Genetics
Zeinalzadeh, Elham E; Valerievich Yumashev, Alexey A; Rahman, Heshu Sulaiman HS; Marofi, Faroogh F; Shomali, Navid N; Kafil, Hossein Samadi HS; Solali, Saeed S; Sajjadi-Dokht, Mehdi M; Vakili-Samiani, Sajjad S; Jarahian, Mostafa M; Hagh, Majid Farshdousti MF
Publication Date: 2021

Variant appearance in text: DNMT3A: p66a
PubMed Link: 34992627
Variant Present in the following documents:
  • Main text
  • fgene-12-703883.pdf
View BVdb publication page